Blood Sample Protein Measurement Analysis
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
|---|---|
| State: | District of Columbia |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | May 1, 2026 |
| Due Date: | May 15, 2026 |
| Solicitation No: | 36C24526Q0481 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: May 01, 2026 03:45 pm EDT
- Original Response Date: May 15, 2026 03:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: May 30, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
-
NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
Washington , DC 20422USA
The Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study. Advanced prostate cancer remains a leading cause of cancer morbidity and mortality among Veterans, yet validated circulating biomarkers that predict treatment response or early disease progression are lacking. Current clinical decision-making relies primarily on PSA kinetics and radiographic imaging, which have well-recognized limitations in sensitivity and lead time. The goal of the research study is to generate reproducible, high-quality proteomic data from the study’s longitudinal plasma specimens so that the VA study team can conduct exploratory analyses linking circulating proteomic changes to clinical outcomes, ultimately informing future biomarker validation studies and precision oncology strategies for Veterans with advanced prostate cancer.
- 8849 International Drive Suite 215
- LINTHICUM , MD 21090
- USA
- Veronica B. Dillard
- veronica.dillard@va.gov
- May 01, 2026 03:45 pm EDTSources Sought (Original)
See Also
Follow Cooperative Driving Automation (CDA) Small-Scale Industry Prototype Active Contract Opportunity Notice ID
TRANSPORTATION, DEPARTMENT OF
Due by 9/28/2026
Follow Research Initiatives in Support of FHWA Next Generation Structural Materials and Systems
TRANSPORTATION, DEPARTMENT OF
Due by 4/01/2029
Follow Federal Bureau of Investigation (FBI) - Office of Chief Information Officer (OCIO)
JUSTICE, DEPARTMENT OF
Due by 5/16/2027
Follow FTA Broad Agency Announcement (FY26) -- "Research Initiatives in Support of Safety,
TRANSPORTATION, DEPARTMENT OF
Due by 10/19/2026